It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Acetylcholine release in the hippocampus plays a central role in the formation of new memory representations. An influential but largely untested theory proposes that memory formation requires acetylcholine to enhance responses in CA1 to new sensory information from entorhinal cortex whilst depressing inputs from previously encoded representations in CA3. Here, we show that excitatory inputs from entorhinal cortex and CA3 are depressed equally by synaptic release of acetylcholine in CA1. However, feedforward inhibition from entorhinal cortex exhibits greater depression than CA3 resulting in a selective enhancement of excitatory-inhibitory balance and CA1 activation by entorhinal inputs. Entorhinal and CA3 pathways engage different feedforward interneuron subpopulations and cholinergic modulation of presynaptic function is mediated differentially by muscarinic M3 and M4 receptors, respectively. Thus, our data support a role and mechanisms for acetylcholine to prioritise novel information inputs to CA1 during memory formation.
In this study, acetylcholine release is shown to reorganise hippocampal CA1 inhibitory networks resulting in prioritisation of entorhinal input over CA3 input. This is achieved by activation of a combination of M3 and M4 muscarinic receptors.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 University of Bristol, University Walk, Center for Synaptic Plasticity, School of Physiology, Pharmacology and Neuroscience, Bristol, UK (GRID:grid.5337.2) (ISNI:0000 0004 1936 7603)
2 Sosei Heptares, Steinmetz Building, Granta Park, Great Abingdon, Cambridge, UK (GRID:grid.5337.2); OMass Therapeutics Ltd, The Schrödinger Building, Oxford, UK (GRID:grid.5337.2)
3 Sosei Heptares, Steinmetz Building, Granta Park, Great Abingdon, Cambridge, UK (GRID:grid.5337.2)
4 University of Cambridge, Department of Psychiatry, Cambridge, UK (GRID:grid.5335.0) (ISNI:0000000121885934)
5 Sosei Heptares, Steinmetz Building, Granta Park, Great Abingdon, Cambridge, UK (GRID:grid.5335.0)